Search Results
(-)-WIN 55,212-3 (mesylate) 50 mg | ≥98%
Cayman Chemical
(-)-WIN 55,212-3 (mesylate)
(-)-WIN 55,212-3 (mesylate) 25 mg | ≥98%
Cayman Chemical
(-)-WIN 55,212-3 (mesylate)
(-)-WIN 55,212-3 (mesylate) 10 mg | ≥98%
Cayman Chemical
(-)-WIN 55,212-3 (mesylate)
(-)-WIN 55,212-3 (mesylate) 5 mg | ≥98%
Cayman Chemical
(-)-WIN 55,212-3 (mesylate)
(-)-WIN 55,212-3 mesylate Please inquire | ≥98%
BOC Sciences
(−)-WIN 55,212-3 is an aminoalkylindole derivative which acts as a competitive neutral antagonist of the human cannabinoid CB2 receptor and presumably express the CB1 receptor. It also weakly antagonizes the melatonin MT1 and muscarinic M4 receptors but has no effect on several other G protein-coupled receptors.
More Information Supplier Page(-)-Xestospongin C 10ug | 90%
APEXBIO TECHNOLOGY LLC
IP3-dependent Ca2+ release inhibitor Membrane Transporter/Ion Channel|Calcium Channel
More Information Supplier Page(-)-Xestospongin C
(-)-Xestospongin C 50ug | 90%
APEXBIO TECHNOLOGY LLC
IP3-dependent Ca2+ release inhibitor Membrane Transporter/Ion Channel|Calcium Channel
More Information Supplier Page(-)-Xestospongin C
(-)-Xestospongin C 100ug | 90%
APEXBIO TECHNOLOGY LLC
IP3-dependent Ca2+ release inhibitor Membrane Transporter/Ion Channel|Calcium Channel
More Information Supplier Page(-)-Xestospongin C
(-)-Xestospongin C 250ug | 90%
APEXBIO TECHNOLOGY LLC
IP3-dependent Ca2+ release inhibitor Membrane Transporter/Ion Channel|Calcium Channel
More Information Supplier Page(-)-Xestospongin C
(-)-Xestospongin C Please inquire | Purity Not Available
BOC Sciences
(-)-Xestospongin C is a potent and reversible inhibitor of IP3 receptor that reguates calcium release. (-)-Xestospongin C has been found to inhibit bradykinin-induced Ca2+ release in PC12 cells and attenuate PHP-induced IL-2 production in Jurkat T cells, but exhibits no effect on ryanodine receptor-mediated Ca2+ release in PC12 cells.
More Information Supplier Page